Technology Solutions

Greenphire ClinCard System, Duke collaborate

Thursday, August 27, 2015

Greenphire, a King of Prussia, Pa.-based provider of payment technology for the clinical trials industry, has announced that Duke University has selected its ClinCard system to support financial data management and tracking in more than 3,000 clinical studies that the organization conducts each year. As one of the largest biomedical research enterprises in the U.S., Duke will implement Greenphire’s solution to automate the management of payments, and associated data, it makes to research participants annually.

[Read More]

Burning Rock, Illumina collaborate

Wednesday, August 26, 2015

Burning Rock, a Guangzhou, China-based diagnostics company, has entered into an agreement to develop advanced clinical applications for molecular diagnostics in oncology based on Illumina’s next-generation sequencing (NGS) technology. The collaboration highlights the  importance of genomics to improve healthcare in China.

[Read More]

DrugDev hiring in Massachusetts

Monday, August 24, 2015

DrugDev, a health technology company, is putting out a call to SaaS developers in the Boston area to join the team behind a cloud-based software platform that enables clinical trial sponsors, CROs and sites to do more clinical trials together.

[Read More]

Roche app measures Parkinson’s disease fluctuations

Monday, August 17, 2015

Roche Pharma Research & Early Development (pRED) has developed a smartphone-based monitoring system for those with Parkinson’s disease (PD) that complements the traditional physician-led assessments with automated tests that continuously measure their symptom fluctuations. It could be the first time that such an app has been used to measure disease and symptom severity in a medicine development program in PD.

[Read More]

Early inroads for wearable devices in clinical trials

Saturday, August 15, 2015

It is nearly impossible today to avoid the growing number of commercially available wearable devices capable of gathering health information. These devices—typically placed on a wrist, arm or chest—hold promise for col­lecting, transmitting and integrating objective experiential data in real time and in aiding the analysis of a much higher volume of data from a significantly larger number of patients. But based on interviews with industry profession­als, the conceptual promise of wearable devices in clinical trials remains largely that. Adoption is in its very earliest stages.

[Read More]

BRANY launches new license option for Protocol Builder

Friday, August 14, 2015

Protocol Builder, a cloud-based solution for investigator-initiated clinical trials, now is available to individual researchers, including medical residents and fellows, according to the Biomedical Research Alliance of New York (BRANY), the developer of the system and a national organization providing clinical research support solutions such as IRB review, trial contracting/budgeting, and auditing and monitoring to hospitals and academic medical centers.

[Read More]

Roche acquires GeneWEAVE

Thursday, August 13, 2015

Roche has signed a definitive agreement to acquire GeneWEAVE BioSciences, a Los Gatos, Calif.-based, privately held company focused on clinical microbiology diagnostics solutions. Roche will pay GeneWEAVE shareholders $190 million upfront and up to $235 million in contingent product related milestones. The transaction is subject to customary closing conditions and, once closed, GeneWEAVE will be integrated into Roche Molecular Diagnostics.

[Read More]